Bass AJ - Search Results

1

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.

McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA. McCune SL, et al. Among authors: bass aj. Leuk Lymphoma. 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597. Leuk Lymphoma. 2002. PMID: 12148879

2

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.

Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO. Rizzieri DA, et al. Among authors: bass aj. J Clin Oncol. 2002 Feb 1;20(3):674-9. doi: 10.1200/JCO.2002.20.3.674. J Clin Oncol. 2002. PMID: 11821447 Clinical Trial.

3

CD52 expression in mantle cell lymphoma.

Bass AJ, Gong J, Nelson R, Rizzieri DA. Bass AJ, et al. Leuk Lymphoma. 2002 Feb;43(2):339-42. doi: 10.1080/10428190290006125. Leuk Lymphoma. 2002. PMID: 11999566

4

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.

Bass AJ, Gockerman JP, Hammett E, DeCastro CM, Adams DJ, Rosner GL, Payne N, Davis P, Foster T, Moore JO, Rizzieri DA. Bass AJ, et al. J Clin Oncol. 2002 Jul 1;20(13):2995-3000. doi: 10.1200/JCO.2002.08.166. J Clin Oncol. 2002. PMID: 12089230 Clinical Trial.

5

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival.

de Klerk LK, Patel AK, Derks S, Pectasides E, Augustin J, Uduman M, Raman N, Akarca FG, McCleary NJ, Cleary JM, Rubinson DA, Clark JW, Fitzpatrick B, Brais LK, Cavanaugh ME, Rode AJ, Jean MG, Lizotte PH, Nazzaro MJ, Severgnini M, Zheng H, Fuchs CS, Enzinger PC, Bass AJ. de Klerk LK, et al. Among authors: bass aj. J Immunother Cancer. 2021 Sep;9(9):e002472. doi: 10.1136/jitc-2021-002472. J Immunother Cancer. 2021. PMID: 34593617 Free PMC article. Clinical Trial.

6

Hitting the Target in BRAF-Mutant Colorectal Cancer.

Nagaraja AK, Bass AJ. Nagaraja AK, et al. Among authors: bass aj. J Clin Oncol. 2015 Dec 1;33(34):3990-2. doi: 10.1200/JCO.2015.63.7793. Epub 2015 Oct 12. J Clin Oncol. 2015. PMID: 26460302 No abstract available.

7

Managing advanced colorectal cancer: have we reached the PEAK with current therapies?

Wolpin BM, Bass AJ. Wolpin BM, et al. Among authors: bass aj. J Clin Oncol. 2014 Jul 20;32(21):2200-2. doi: 10.1200/JCO.2014.55.6316. Epub 2014 Jun 16. J Clin Oncol. 2014. PMID: 24934780 No abstract available.

8

Family history and survival after colorectal cancer diagnosis.

Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Bass AJ, et al. Cancer. 2008 Mar 15;112(6):1222-9. doi: 10.1002/cncr.23294. Cancer. 2008. PMID: 18219663 Free article.

9

ERBB2 emerges as a new target for colorectal cancer.

Pectasides E, Bass AJ. Pectasides E, et al. Among authors: bass aj. Cancer Discov. 2015 Aug;5(8):799-801. doi: 10.1158/2159-8290.CD-15-0730. Cancer Discov. 2015. PMID: 26243861 Free PMC article.

10

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Goedegebuure RSA, de Klerk LK, Bass AJ, Derks S, Thijssen VLJL. Goedegebuure RSA, et al. Among authors: bass aj. Front Immunol. 2019 Jan 14;9:3107. doi: 10.3389/fimmu.2018.03107. eCollection 2018. Front Immunol. 2019. PMID: 30692993 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page